| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K |
| P698 | PubMed publication ID | 9663471 |
| P50 | author | Graciela S Alarcón | Q67485107 |
| John D Reveille | Q67485113 | ||
| P2093 | author name string | Ahn C | |
| Moulds JM | |||
| Friedman AW | |||
| Roseman J | |||
| Straaton KV | |||
| Baethge B | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death | Q33403579 | ||
| Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study | Q35606678 | ||
| Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis) | Q35822079 | ||
| B-Lymphocyte Alloantigens Associated with Systemic Lupus Erythematosus | Q40686448 | ||
| Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus | Q42686747 | ||
| Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes | Q43970492 | ||
| C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus | Q43988977 | ||
| Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus | Q46197685 | ||
| HLA-DR2-DRB1 allele frequencies in Dispositive black Americans with and without systemic lupus erythematosus | Q46568484 | ||
| Morbidity of systemic lupus erythematosus: role of race and socioeconomic status | Q46891297 | ||
| Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. | Q53887704 | ||
| DNA polymorphism of major histocompatibility complex class II and class III genes in systemic lupus erythematosus | Q57089759 | ||
| Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern chinese | Q58143723 | ||
| P433 | issue | 7 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| socioeconomics | Q1643441 | ||
| P304 | page(s) | 1161-1172 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture | |
| P478 | volume | 41 |
| Q46080033 | 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study |
| Q30278514 | A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus |
| Q51381212 | A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients. |
| Q87724555 | ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity |
| Q38108851 | Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets |
| Q37271563 | Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. |
| Q35953274 | African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV) |
| Q37593029 | Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations |
| Q34749170 | An update on genetic studies of systemic lupus erythematosus |
| Q46484623 | Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. |
| Q35146164 | Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis |
| Q33375598 | Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients |
| Q36049206 | Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans |
| Q34130000 | Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais. |
| Q52932212 | CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded. |
| Q34598372 | Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin |
| Q38906343 | Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE. |
| Q39363987 | Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus |
| Q37754585 | Complement deficiency and systemic lupus erythematosus: consensus and dilemma |
| Q36152835 | Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences |
| Q37356406 | Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. |
| Q44369790 | Disparities in renal replacement in lupus nephritis: current practice and future implications |
| Q33750407 | Diversity in presenting manifestations of systemic lupus erythematosus in children |
| Q34161393 | Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort |
| Q36676984 | Ethnic and geographical differences in systemic lupus erythematosus: an overview |
| Q45212503 | Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). |
| Q43877173 | Ethnicity and lupus nephritis: an Australian single centre study |
| Q46496211 | Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes |
| Q34169570 | Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). |
| Q33344758 | Familiality and co-occurrence of clinical features of systemic lupus erythematosus |
| Q35216982 | Fcgamma receptors in the initiation and progression of systemic lupus erythematosus |
| Q33380972 | Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort |
| Q36625351 | Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy |
| Q38439633 | Genetic architectures of seropositive and seronegative rheumatic diseases |
| Q34108801 | Genetics and systemic lupus erythematosus |
| Q73881319 | Genetics and systemic lupus erythematosus |
| Q33893349 | Genetics of systemic lupus erythematosus. Clinical implications |
| Q44126704 | High prevalence of lateral knee osteoarthritis in Beijing Chinese compared with Framingham Caucasian subjects |
| Q37548732 | Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. |
| Q37625577 | Infection--genetics relationship in systemic lupus erythematosus. |
| Q33653146 | Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort |
| Q33932528 | Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE). |
| Q33867927 | Links between complement abnormalities and systemic lupus erythematosus |
| Q47627636 | Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus |
| Q41912513 | Lupus in Germany: analysis within the German lupus self-help organization (LULA) |
| Q46720386 | Lupus nephritis in an Afro-Caribbean population: renal indices and clinical outcomes |
| Q35637001 | MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus |
| Q35549151 | MHC region and risk of systemic lupus erythematosus in African American women |
| Q46592474 | Outcomes in African Americans and Hispanics with lupus nephritis. |
| Q34946314 | PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes |
| Q33511924 | Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX) |
| Q36245311 | Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis |
| Q33448450 | Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort |
| Q47100353 | Predictors of incident proteinuria among patients with SLE. |
| Q37659608 | Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. |
| Q28377438 | Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity |
| Q35549094 | Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus |
| Q64124003 | Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP) |
| Q35083469 | Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus |
| Q36790796 | Sm antibodies increase risk of death in systemic lupus erythematosus |
| Q49028552 | Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women |
| Q37327039 | Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus |
| Q37754835 | Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture? |
| Q37921757 | Systemic lupus erythematosus in Hispanics |
| Q43728316 | Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement |
| Q46329612 | Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity |
| Q44148062 | Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage |
| Q40461525 | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. |
| Q45099953 | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage |
| Q35637240 | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study |
| Q35637820 | Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time |
| Q33379105 | Systemic lupus erythematosus in the Fars Province of Iran. |
| Q46843827 | Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture |
| Q46684489 | Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory |
| Q44003915 | Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores |
| Q75828790 | Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity |
| Q35873395 | Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis |
| Q46430510 | Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture |
| Q34082803 | Systemic lupus erythematosus, complement deficiency, and apoptosis |
| Q73501025 | The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms |
| Q38026775 | The beneficial role of vitamin D in systemic lupus erythematosus (SLE). |
| Q28730944 | The biological significance of evolution in autoimmune phenomena |
| Q38784456 | The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. |
| Q38936647 | The global burden of SLE: prevalence, health disparities and socioeconomic impact |
| Q38885199 | The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians. |
| Q30241539 | The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases. |
| Q33741165 | The role of genetic factors in autoimmune disease: implications for environmental research |
| Q36614958 | Unraveling the genetics of systemic lupus erythematosus |
| Q39002132 | Update on Lupus Nephritis |
| Q33723441 | Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome |
Search more.